Trial intelligence / Profile preview

Exploratory dOFM bioequivalence study of topical acyclovir in healthy volunteers

2013-005062-19Phase 4Completed

Sponsor
Medical University of Graz
Start
Dec 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of aciclovir in herpes simplex (HSV), sponsored by Medical University of Graz. Primary endpoint: AUC0-t of acyclovir in dermal interstitial fluid. Started Dec 2014; status: completed.

02

Drugs

aciclovir
03

Conditions

herpes simplex (HSV)

Beyond the preview

Go deeper on 2013-005062-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-005062-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call